Target intelligence / Profile preview

TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa pseudogene

Molecular classification: Other (classified specifically as a pseudogene)

Overview

ENSG00000253550 refers to a pseudogene related to TAF9, a protein that in its functional form is a subunit of the TFIID transcription factor complex involved in the initiation of RNA polymerase II-dependent transcription[1][4][5]. However, this particular entry (ENSG00000253550/LOC101928016) is not itself protein coding, nor is it implicated in any known biological or disease process. Its annotated function as a pseudogene means it is a genetic relic, not producing functional protein and not considered a therapeutic target[5].

Other names: LOC101928016TAF9 pseudogeneTAF9 RNA polymerase II pseudogene

Beyond the preview

Go deeper on TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa pseudogene.

Explore the full profile